High Cbd Chemotypes

High-CBD chemotypes represent cannabis plants bred or selected to produce elevated cannabidiol (CBD) levels, often with minimal THC or balanced THC:CBD ratios. These chemotypes emerged from selective breeding programs prioritizing cannabinoid diversity rather than single-compound dominance. Lineage records frequently report CBD-dominant phenotypes arising from crosses involving Ruderalis genetics, Swiss landrace hemp varieties, and therapeutic-focused breeding lines developed since the 2010s. The biochemical pathway that produces CBD instead of THC is controlled by a single genetic locus (the CBDAS/THCAS enzyme ratio), making these chemotypes relatively stable across generations once established. Breeders working with high-CBD lines often prioritize consistent cannabinoid ratios, terpene retention, and phenotypic stability for research and commercial cultivation.

High-CBD chemotypes serve as foundational genetics for breeding programs seeking non-intoxicating or balanced-ratio varieties, and are frequently crossed with flavor or yield-focused lines to introduce CBD production while maintaining desirable agronomic traits. Their genetic architecture is valuable for understanding cannabinoid biosynthesis pathways.